前驱期快速眼动睡眠行为障碍向神经退行性疾病的演变:一项回顾性纵向病例对照研究
该回顾性纵向病例对照研究纳入44例前驱期快速眼动睡眠行为障碍(pRBD)患者和44例匹配对照,随访8.2±3.3年,发现患者快速眼动睡眠期肌电活动显著增加,66%进展为完全性RBD,且pRBD患者神经退行性疾病风险升高(调整风险比=2.95,95%CI=1.02-8.54)。
要点
- pRBD患者快速眼动睡眠期颏肌和胫骨前肌联合肌电水平随随访显著升高,年均增加3.9%。
- 基线肌电活动可区分pRBD与对照,联合颏肌任何及双侧胫骨前肌时相肌电的曲线下面积为0.97。
- pRBD患者神经退行性疾病风险高于对照(调整风险比=2.95,95%CI=1.02-8.54)。
核心结论
- pRBD在病理生理和神经退行性结局上均呈预测性进展。
研究设计与样本
- 回顾性纵向病例对照研究,1997年至2018年在香港中文大学睡眠评估单元招募基线无神经退行性疾病的pRBD患者和年龄、性别、随访时长匹配的对照,共44例患者(年龄67.4±8.2岁,6例女性)和44例对照。
主要发现
- pRBD患者颏肌和胫骨前肌联合快速眼动睡眠期肌电水平在8.2±3.3年随访中从19.3%±9.7%升至47.3%±27.4%,估计年增加3.9%,29例(66%)达到完全性RBD诊断标准。
- 进展为完全性RBD的患者基线颏肌任何肌电活动6.3%和颏肌任何联合双侧胫骨前肌时相肌电9.1%可区分pRBD与对照,曲线下面积分别为0.88(0.78-0.98)和0.97(0.92-1.00)。
- pRBD患者神经退行性疾病风险高于对照(9例帕金森病、3例路易体痴呆 vs 5例阿尔茨海默病;调整风险比=2.95,95%CI=1.02-8.54)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Individuals with a history of recurrent dream-enactment behaviors, but with subthreshold REM sleep without atonia levels for REM sleep behavior disorder (RBD) diagnosis, are currently classified to have prodromal RBD (pRBD). However, the REM sleep-elevated EMG diagnostic cutoff, progression trajectory, and long-term neurodegenerative outcome of pRBD are not well understood. This study aimed to delineate the evolution of REM sleep EMG levels, determine the EMG cutoff score for diagnosing pRBD, and examine the risk for neurodegenerative diseases of pRBD. METHODS: This retrospective longitudinal case-control study recruited patients with pRBD and age-matched, sex-matched, and follow-up duration-matched controls who were free of neurodegenerative disease at baseline in the Sleep Assessment Unit, the Chinese University of Hong Kong from 1997 to 2018. Patients and controls underwent clinical and video-polysomnography (PSG) assessments at baseline and follow-up(s). REM sleep EMG activity level on mentalis and anterior tibialis (AT) muscles on video-PSG at each visit was scored. The diagnosis of neurodegenerative diseases was confirmed by a neurologist. RESULTS: A total of 44 patients (age 67.4 ± 8.2 years, 6 females) and 44 controls were recruited. The combined REM sleep EMG level on mentalis and AT muscles of patients with pRBD significantly increased during 8.2 ± 3.3 years of follow-up (from 19.3% ± 9.7% to 47.3% ± 27.4% with estimated annual increase of 3.9%), yielding 29 patients with pRBD (66%) meeting the full-blown RBD diagnostic criteria. Baseline REM sleep mentalis and AT muscles EMG activity of patients who developed full-blown RBD could favorably differentiate pRBD from controls (6.3% for mentalis "any" and 9.1% for combination of mentalis any and bilateral AT muscles phasic EMG with an area under the curve of 0.88 [0.78-0.98] and 0.97 [0.92-1.00], respectively). Patients with pRBD had a higher risk for neurodegenerative diseases (9 developed Parkinson disease and 3 developed dementia with Lewy bodies) when compared with controls (5 developed Alzheimer disease, adjusted hazard ratio = 2.95, 95% CI = 1.02-8.54). DISCUSSION: pRBD has a predictive progression in both pathophysiology and neurodegenerative outcome. This finding has significant implications to the nosological status of pRBD, the current REM sleep-related EMG diagnostic criteria, spectrum concept of RBD, and future neuroprotective intervention. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that EMG activity during REM sleep predicts the development of pRBD.
引用
- Liu Y, Zhang J, Chau SWH, et al. Evolution of Prodromal REM Sleep Behavior Disorder to Neurodegeneration: A Retrospective Longitudinal Case-Control Study. Neurology. 2022. PMID: 35550550. doi:10.1212/WNL.0000000000200707
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。